Literature DB >> 33493347

Why clinicians should know about Mendelian randomization.

Sizheng Steven Zhao1,2, Sarah L Mackie3,4, Jie Zheng2,5.   

Abstract

Mesh:

Year:  2021        PMID: 33493347     DOI: 10.1093/rheumatology/keab007

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  The impact of education inequality on rheumatoid arthritis risk is mediated by smoking and body mass index: Mendelian randomization study.

Authors:  Sizheng Steven Zhao; Michael V Holmes; Jie Zheng; Eleanor Sanderson; Alice R Carter
Journal:  Rheumatology (Oxford)       Date:  2022-05-05       Impact factor: 7.046

2.  Graves' Disease and Rheumatoid Arthritis: A Bidirectional Mendelian Randomization Study.

Authors:  Dide Wu; Wei Xian; Shubin Hong; Boyuan Liu; Haipeng Xiao; Yanbing Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-17       Impact factor: 5.555

3.  COVID-19 is associated with the risk of cardiovascular disease death: A two-sample Mendelian randomization study.

Authors:  Jia-Peng Miao; Xiao-Yu Gu; Rui-Zheng Shi
Journal:  Front Cardiovasc Med       Date:  2022-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.